Across TCGA pan-cancer cohorts, LMAN1L mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LMAN1L’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LMAN1L mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types LMAN1L is over-expressed in tumor.
COAD and LSCC are the cancer types where LMAN1L tumor–normal differential expression is most reproducible.